Latest News

Subcutaneous nivolumab approved in EU, Canada for solid tumors
Subcutaneous nivolumab approved in EU, Canada for solid tumors

May 28th 2025

The approvals are supported by findings from the phase 3 CheckMate-67T trial.

Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy
Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy

May 28th 2025

Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test
Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test

May 27th 2025

Combination therapy linked to longer OS vs ADT in veterans with mHSPC
Combination therapy linked to longer OS vs ADT in veterans with mHSPC

May 27th 2025

Kidney stones | Image Credit: © airborne77 - stock.adobe.com
Clarifying CPT 52353 billing for same-side stone cases

May 26th 2025

Latest News

© 2025 MJH Life Sciences

All rights reserved.